![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
Innovation in Kidney Transplantation and Post-care (Talaris Therapeutics) (American Association of Kidney Patients) View |
![]() |
FREEDOM-1: A New Frontier in Living Donor Kidney Transplant (Talaris) View |
![]() |
Ch. 3: Protocol for Living Donor Kidney Transplant with FCR001, Designed to Induce Immune Tolerance (Talaris) View |
![]() |
FCR001, an investigational cell therapy: Harnessing the power of immune tolerance in LDKT for HCP (Talaris) View |
![]() |
Talaris Therapeutics (Alliance for Regenerative Medicine) View |
![]() |
Ch. 6: FREEDOM-2 Phase 2 Trial with FCR001, Designed to Induce Immune Tolerance in LDKT Recipients (Talaris) View |
![]() |
Talaris Therapeutics (Alliance for Regenerative Medicine) View |
![]() |
FREEDOM-1 and FREEDOM-2 Webinar (Alport Syndrome Foundation) View |
![]() |
Harnessing the Power of Immune Tolerance in Living-Donor Kidney Transplant (GlomCon Foundation) View |
![]() |
Immune-tolerance is the pinnacle of transplantation (UCLA Health) View |